… At the end of the treatment period with low-dose heparin … with the period without heparin.
The present results indicate … fibrinogen levels in patients with ischemic heart disease, possibly …

… In addition, patients were required to have evidence of underlying ischemic heart disease
… or invasive testing suggesting ischemic heart disease. Exclusion criteria included the …

… can be used in patients undergoing percutaneous coronary … treatment of patients with coronary
heart disease (CHD) … UFH in the PCI for patients with coronary heart disease (CHD) and …

… the patient is transported to a comfortable bed or hospital. Therefore, in coronary artery disease,
we believe that heparin should be used in patients … heart disease, where the hematocrit …

… new thrombotic event during heparin treatment, or unexplained heparin resistance, are
indications of HITT. Restoration of the platelet count after heparin withdrawal further strengthens …

… molecular weight heparin enoxaparin with unfractionated heparin (UFH) for the prevention
of venous thromboembolic disease in patients with heart failure or severe respiratory disease. …

… required during open-heart surgery. The risk of adding aspirin to a short course of regular …
of heparin is much lower, however, and is acceptable in patients with ischemic heart disease. …

… future risk of coronary heart disease in initially healthy middle-aged men: results from the
MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsberg Cohort …

… required to have evidence of underlying ischemic heart disease, as manifested by one of …
ischemic heart disease. Written, informed consent was obtained from all patients, and the study …

… heparin binding, thereby reducing its anticoagulant activity. The levels of these heparin-binding
proteins vary among patients. … to heparin and to the phenomenon of heparin resistance. …